Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
pgyYZ94jvjNy3wFc
Listen
